Related Experiment Video
Updated: Jul 16, 2026
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
[Effects of triptolide on prostate carcinoma in mouse RM-1 cells]
Rui Zhang1, Peng-yu Zhang, Jun Guo
1Department of Andrology, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang 150040, China.
Objective:
To study the effect of Triptolide (TL) on the growth of prostate carcinoma cell line, and analyze its function and mechanism in anti-prostate cancer.
Methods:
MTT experiments were performed to examine the inhibiting effect of TL on the proliferation of RM-1 cells, cell morphological changes observed by acridine staining, cellular cycles and apoptosis peak analyzed by flow cytometry, the apoptosis fracture zone investigated with DNA electrophoresis, and the expressions of caspase-3 and bcl-2 mRNA in RM-1 cells examined by RT-PCR.
Results:
The results of MTT experiments showed that after the treatment of TL (5, 10, 20, 40 and 80 ng/ml), the RM-1 cell proliferation inhibition rates were 9.8%, 25.1%, 39.2%, 48.8% and 53.2% respectively; 12, 24, 36 and 48 hours after the treatment of TL (10 and 20 ng/ml), the cell proliferation inhibition rates were 8.4%, 25.1%, 36.1%, 42.4% and 10.2%, 39.2%, 50.2% and 58.5% respectively. Acridine staining after the TL treatment revealed nucleus condensation, cell membrane invagination, irregular orange particles in the cells and apoptosis morphological changes; flow cytometry tests showed that 48 hours after the TL treatment (10, 20 ng/ml) of RM-1 cells, an obvious apoptosis peak appeared before the G1 stage; 24, 36 and 48 hours after it, DNA "trapezoid" strips could be seen; the caspase-3 mRNA expression in the TL treated cells was higher, and the bcl-2 mRNA expression was lower than in the controls.
Conclusion:
TL can decrease bcl-2 expression, increase caspase-3 expression, induce apoptosis of prostate carcinoma cells, and consequently inhibit the proliferation of RM-1 cells in mice.
Insights
Triptolide (TL) effectively inhibits prostate cancer cell growth by inducing apoptosis. This natural compound decreases bcl-2 expression and increases caspase-3 expression, leading to reduced proliferation of cancer cells.
Area of Science:
- Molecular Biology
- Cancer Research
- Pharmacology
Context:
- Prostate carcinoma is a significant health concern.
- Investigating novel therapeutic agents for prostate cancer is crucial.
- Triptolide (TL) is a compound with potential anti-cancer properties.
Purpose:
- To evaluate the anti-prostate cancer effects of Triptolide (TL).
- To analyze the mechanism by which TL inhibits prostate cancer cell growth.
- To assess TL's impact on cell proliferation, apoptosis, and gene expression in prostate cancer cells.
Summary:
- MTT assays demonstrated dose- and time-dependent inhibition of RM-1 prostate cancer cell proliferation by TL.
- Acridine staining and flow cytometry revealed TL induces apoptosis, characterized by morphological changes and an apoptosis peak.
- TL treatment altered gene expression, decreasing bcl-2 and increasing caspase-3 mRNA levels, indicative of apoptotic pathway activation.
Impact:
- Triptolide (TL) shows significant potential as an anti-cancer agent for prostate carcinoma.
- Understanding TL's mechanism provides insights into targeted apoptosis induction for cancer therapy.
- This study supports further research into TL for prostate cancer treatment development.
